期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
右美托咪定复合罗哌卡因双肋缘下腹横肌平面阻滞对开腹肝切术的镇痛观察
1
作者 杜燕玲 王声 高孝坦 《外科研究与新技术》 2023年第3期203-205,220,共4页
目的探索右美托咪定(DEX)复合罗哌卡因(ROP)双肋缘下腹横肌平面(TAP)阻滞对开腹肝切术的镇痛效果。方法选取2021年1月—2022年12月收治的100例开腹肝切术患者作为研究对象,随机分为ROP组(n=50)和ROP+DEX组(n=50)。所有患者均给予气管插... 目的探索右美托咪定(DEX)复合罗哌卡因(ROP)双肋缘下腹横肌平面(TAP)阻滞对开腹肝切术的镇痛效果。方法选取2021年1月—2022年12月收治的100例开腹肝切术患者作为研究对象,随机分为ROP组(n=50)和ROP+DEX组(n=50)。所有患者均给予气管插管,借助超声引导行双肋缘下TAP阻滞;ROP组给予0.375%浓度的罗哌卡因40 mL进行麻醉,ROP+DEX组给予罗哌卡因联合右美托咪定(1μg/kg)进行麻醉。肝切术完成后,于缝合伤口前给予经静脉病人自控(PCIA)镇痛。观察并比较两组术后心率及平均动脉压等血流动力学指标、镇痛效果及不良反应发生情况。结果ROP+DEX组术后30、60、120 min时的心率、平均动脉压均低于ROP组(P<0.05);ROP+DEX组术后首次主诉疼痛时间显著晚于ROP组(P<0.01);ROP+DEX组术后2、6 h时视觉模拟评分(VAS)均明显低于ROP组(P<0.01);两组术后24 h内总体不良反应发生率比较差异无统计学意义(P>0.05)。结论罗哌卡因联合右美托咪定双肋缘下TAP阻滞开腹肝切术的术后镇痛效果明显,可显著延长镇痛时间,减轻疼痛,稳定循环,以提早实现患者下床活动的目标。 展开更多
关键词 右美托咪啶 罗哌卡因 开腹肝切术 腹横肌平面阻滞 镇痛效果
下载PDF
Meta-analysis of laparoscopic vs open liver resection for hepatocellular carcinoma 被引量:27
2
作者 Jun-Jie Xiong Kiran Altaf +6 位作者 Muhammad A Javed Wei Huang Rajarshi Mukherjee Gang Mai Robert Sutton Xu-Bao Liu Wei-Ming Hu 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第45期6657-6668,共12页
AIM:To conduct a meta-analysis to determine the safety and efficacy of laparoscopic liver resection(LLR) and open liver resection(OLR) for hepatocellular carcinoma(HCC).METHODS:PubMed(Medline),EMBASE and Science Citat... AIM:To conduct a meta-analysis to determine the safety and efficacy of laparoscopic liver resection(LLR) and open liver resection(OLR) for hepatocellular carcinoma(HCC).METHODS:PubMed(Medline),EMBASE and Science Citation Index Expanded and Cochrane Central Register of Controlled Trials in the Cochrane Library were searched systematically to identify relevant comparative studies reporting outcomes for both LLR and OLR for HCC between January 1992 and February 2012.Two authors independently assessed the trials for inclusion and extracted the data.Meta-analysis was performed using Review Manager Version 5.0 software(The Cochrane Collaboration,Oxford,United Kingdom).Pooled odds ratios(OR) or weighted mean differences(WMD) with 95%CI were calculated using either fixed effects(Mantel-Haenszel method) or random effects models(DerSimonian and Laird method).Evaluated endpoints were operative outcomes(operation time,intraoperative blood loss,blood transfusion requirement),postoperative outcomes(liver failure,cirrhotic decompensation/ascites,bile leakage,postoperative bleeding,pulmonary complications,intraabdominal abscess,mortality,hospital stay and oncologic outcomes(positive resection margins and tumor recurrence).RESULTS:Fifteen eligible non-randomized studies were identified,out of which,9 high-quality studies involving 550 patients were included,with 234 patients in the LLR group and 316 patients in the OLR group.LLR was associated with significantly lower intraoperative blood loss,based on six studies with 333 patients [WMD:-129.48 mL;95%CI:-224.76-(-34.21) mL;P = 0.008].Seven studies involving 416 patients were included to assess blood transfusion requirement between the two groups.The LLR group had lower blood transfusion requirement(OR:0.49;95%CI:0.26-0.91;P = 0.02).While analyzing hospital stay,six studies with 333 patients were included.Patients in the LLR group were found to have shorter hospital stay [WMD:-3.19 d;95%CI:-4.09-(-2.28) d;P < 0.00001] than their OLR counterpart.Seven studies including 416 patients were pooled together to estimate the odds of developing postoperative ascites in the patient groups.The LLR group appeared to have a lower incidence of postoperative ascites(OR:0.32;95%CI:0.16-0.61;P = 0.0006) as compared with OLR patients.Similarly,fewer patients had liver failure in the LLR group than in the OLR group(OR:0.15;95%CI:0.02-0.95;P =0.04).However,no significant differences were found between the two approaches with regards to operation time [WMD:4.69 min;95%CI:-22.62-32 min;P = 0.74],bile leakage(OR:0.55;95%CI:0.10-3.12;P = 0.50),postoperative bleeding(OR:0.54;95%CI:0.20-1.45;P = 0.22),pulmonary complications(OR:0.43;95%CI:0.18-1.04;P = 0.06),intra-abdominal abscesses(OR:0.21;95%CI:0.01-4.53;P = 0.32),mortality(OR:0.46;95%CI:0.14-1.51;P = 0.20),presence of positive resection margins(OR:0.59;95%CI:0.21-1.62;P = 0.31) and tumor recurrence(OR:0.95;95%CI:0.62-1.46;P = 0.81).CONCLUSION:LLR appears to be a safe and feasible option for resection of HCC in selected patients based on current evidence.However,further appropriately designed randomized controlled trials should be undertaken to ascertain these findings. 展开更多
关键词 Hepatocellular carcinoma LAPAROSCOPY Open liver resection HEPATECTOMY META-ANALYSIS
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部